Amphastar Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell in Celebration of its 10th Anniversary

Amphastar Pharmaceuticals, Inc. (Nasdaq: AMPH), a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products, visits the Nasdaq MarketSite in Times Square. In honor of the occasion, Co-Founders Dr. Jack Zhang, CEO, and Dr. Mary Luo, COO, accompanied by their Board of Directors and Executive Management, rings the Nasdaq Opening Bell to celebrate their 10 year anniversary of going public.